EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum
Intellectual and Developmental Disabilities (IDD)
Cleft Lip
Eukaryotic Initiation Factor-3
Clinical Sciences
610
Clinical sciences
610 Medicine & health
Deafness
Pediatrics
Congenital
03 medical and health sciences
Rare Diseases
Neurodevelopmental disorder
Clinical Research
Intellectual Disability
Medicine and Health Sciences
Genetics
2.1 Biological and endogenous factors
Altered muscular tone
Humans
ddc:610
Dental/Oral and Craniofacial Disease
Pediatric
Genetics & Heredity
0303 health sciences
Other Medical and Health Sciences
Biomedical and Clinical Sciences
Research
Neurosciences
R
EIF3F gene
Biological Sciences
Brain Disorders
3. Good health
UCLA California Center for Rare Disease
Cleft Palate
Short stature
Neurodevelopmental Disorders
Altered muscular tone ; Deafness ; Behavioral difficulties ; Humans [MeSH] ; Intellectual Disability/genetics [MeSH] ; Medical genetics ; Microcephaly [MeSH] ; Cleft Lip [MeSH] ; Neurodevelopmental Disorders/genetics [MeSH] ; Short stature ; Cleft Palate [MeSH] ; Research ; Eukaryotic Initiation Factor-3 [MeSH] ; Neurodevelopmental disorder
Behavioral difficulties
Microcephaly
Congenital Structural Anomalies
Medicine
4.2 Evaluation of markers and technologies
DOI:
10.1186/s13023-021-01744-1
Publication Date:
2021-03-18T22:16:06Z
AUTHORS (40)
ABSTRACT
Abstract
Background
An identical homozygous missense variant in EIF3F, identified through a large-scale genome-wide sequencing approach, was reported as causative in nine individuals with a neurodevelopmental disorder, characterized by variable intellectual disability, epilepsy, behavioral problems and sensorineural hearing-loss. To refine the phenotypic and molecular spectrum of EIF3F-related neurodevelopmental disorder, we examined independent patients.
Results
21 patients were homozygous and one compound heterozygous for c.694T>G/p.(Phe232Val) in EIF3F. Haplotype analyses in 15 families suggested that c.694T>G/p.(Phe232Val) was a founder variant. All affected individuals had developmental delays including delayed speech development. About half of the affected individuals had behavioral problems, altered muscular tone, hearing loss, and short stature. Moreover, this study suggests that microcephaly, reduced sensitivity to pain, cleft lip/palate, gastrointestinal symptoms and ophthalmological symptoms are part of the phenotypic spectrum. Minor dysmorphic features were observed, although neither the individuals’ facial nor general appearance were obviously distinctive. Symptoms in the compound heterozygous individual with an additional truncating variant were at the severe end of the spectrum in regard to motor milestones, speech delay, organic problems and pre- and postnatal growth of body and head, suggesting some genotype–phenotype correlation.
Conclusions
Our study refines the phenotypic and expands the molecular spectrum of EIF3F-related syndromic neurodevelopmental disorder.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (6)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....